BridgeMD
New treatment option for Lung Cancer Patients
Official title Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer
ClinicalTrials.gov ID: NCT07024433
What this study is testing
- What it's testing
- The study focuses on evaluating the effectiveness and safety of tubeless anesthesia in single-port thoracoscopic surgery for early-stage lung cancer patients. Traditional anesthesia methods risk postoperative complications like lung injury and respiratory issues.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age ≥18 years and ≤70 years;
- ECOG performance status score 0-1;
- Good cardiac and pulmonary function;
- Single or multiple peripheral lung nodules planned for single-port thoracoscopic surgery, with or without mediastinal lymph node dissection or...
- Able to comply with the study visit schedule and other protocol requirements;
You likely can't join if
- Obese patients (BMI \>30);
- Patients with difficult intubation or expected complex airway management;
- COPD patients with copious airway secretions;
- Patients with neurological dysfunction or who cannot cooperate while awake;
- Patients expected to have extensive pleural adhesions or with previous lung resection;
- Elderly and frail patients with severe hypoxia (PaO2 \ 50/55 mmHg);
See the full eligibility criteria
- Age ≥18 years and ≤70 years;
- ECOG performance status score 0-1;
- Good cardiac and pulmonary function;
- Single or multiple peripheral lung nodules planned for single-port thoracoscopic surgery, with or without mediastinal lymph node dissection or sampling;
- Able to comply with the study visit schedule and other protocol requirements;
- Signed informed consent and voluntary participation in the study.
- Obese patients (BMI \>30);
- Patients with difficult intubation or expected complex airway management;
- COPD patients with copious airway secretions;
- Patients with neurological dysfunction or who cannot cooperate while awake;
- Patients expected to have extensive pleural adhesions or with previous lung resection;
- Elderly and frail patients with severe hypoxia (PaO2 \ 50/55 mmHg);
- Previous induction chemotherapy or chemoradiotherapy;
- Intraoperative need to isolate the lung to prevent spillage and contamination of the contralateral lung;
- Patients expected to have large surgical wounds and lengthy procedures, clinically assessed as unsuitable;
- Patients whose cardiac and pulmonary function, or overall health, cannot withstand the procedure.
The study team makes the final eligibility decision.
Where it's taking place
- Fuzhou, Fujian, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fuzhou, Fujian, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.